Skip to main content

Syndax Pharmaceuticals Inc 10-K for FY2021

Syndax Pharmaceuticals Inc (SNDX)

10-K 2022-03-01 For: 2021-12-31
View Original
Added on April 09, 2026

About this 10-K

Syndax Pharmaceuticals Inc filed this 10-K on March 1, 2022, covering the fiscal year ended December 31, 2021 (FY2021).

Headline figures

Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$139.71M
up 9109.6% from $1.52M a year earlier
Net income
$24.93M
compared with a net loss of $73.16M a year earlier
Diluted EPS
$0.46
compared with -$1.87 a year earlier